Status:
UNKNOWN
Prospective Evaluation of ENDOSWIR Device Versus Pathology for Squamous Cell Carcinoma of Upper Aerodigestive Tract (ENDOSWIR-VADS)
Lead Sponsor:
University Hospital, Grenoble
Collaborating Sponsors:
Institute for Advanced Biosciences (IAB), Grenoble
Commissariat A L'energie Atomique
Conditions:
Head and Neck Neoplasms
Eligibility:
All Genders
18+ years
Brief Summary
A new medical optical device named ENDOSWIR is tested to determine its ability to determine if tissues are cancer or normal tissue on ex-vivo condition for specimen of ENT squamous cell cancers.
Detailed Description
In vivo short infrared imaging is a real-time, sensitive technique that can be used in the operating room during surgical removal of tumors. It is essential in the surgery of cancers of the upper aer...
Eligibility Criteria
Inclusion
- ENT cancer (buccal or oropharyngeal) for which a surgical resection is planned
- affiliated to the social security
- Having given his non-opposition to participate in the trial.
Exclusion
- Patient protected by law (minor, pregnant or breastfeeding woman, patient under guardianship, subject deprived of liberty or hospitalized under restraint).
- Patients who have received radiotherapy treatment in the VADS area
- Patient with a history of VADS cancer or a synchronous location of VADS cancer.
Key Trial Info
Start Date :
April 11 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2023
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT05318872
Start Date
April 11 2022
End Date
June 30 2023
Last Update
April 12 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.